Aspirin for primary prevention in patients with high cardiovascular risk: insights from CORE-Thailand registry
Abstract Aspirin may be considered for primary prevention in non-elderly patients with high cardiovascular risk. However, contemporary management aimed at aggressive cardiovascular risk factor control may alter benefit-risk ratio of aspirin. Therefore, we aimed to examine the effect of aspirin for p...
Main Authors: | Wanwarang Wongcharoen, Nichanan Osataphan, Narawudt Prasertwitayakij, Pannipa Suwannasom, Swangjit Suraamornkul, Wattana Wongtheptian, Siriluck Gunaparn, Wachiranun Sirikul, Arintaya Phrommintikul |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-41864-1 |
Similar Items
-
Association of the interatrial block and left atrial fibrosis in the patients without history of atrial fibrillation
by: Arintaya Phrommintikul, et al.
Published: (2024-01-01) -
Association of the interatrial block and left atrial fibrosis in the patients without history of atrial fibrillation.
by: Arintaya Phrommintikul, et al.
Published: (2024-01-01) -
Effect of renin angiotensin system inhibitors on long-term major cardiovascular outcomes in patients with high atherosclerotic cardiovascular risk
by: Wanwarang Wongcharoen, et al.
Published: (2023-12-01) -
Population Pharmacokinetics and Dose Optimization Based on Renal Function of Rivaroxaban in Thai Patients with Non-Valvular Atrial Fibrillation
by: Noppaket Singkham, et al.
Published: (2022-08-01) -
Predictive value of heart rate variability on long-term mortality in end-stage kidney disease on hemodialysis.
by: Nichanan Osataphan, et al.
Published: (2023-01-01)